GSK2018682 is a chemical compound that functions as a sphingosine-1-phosphate receptor modulator. It has been investigated in research contexts for potential applications in multiple sclerosis, particularly the relapsing-remitting form.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Etrasimod
pharmaceutical raw material
Maprotiline hydrochloride
pharmaceutical raw material
9-dehydroandrostenedione
pharmaceutical raw material
Alendronic acid-d6
pharmaceutical raw material
Lansoprazole
pharmaceutical raw material
4-[4-[5-(5-chloro-6-propan-2-yloxy-3-pyridinyl)-1,2,4-oxadiazol-3-yl]indol-1-yl]butanoic acid
NFIGDBFIDKDNIG-UHFFFAOYSA-N
CC(C)OC1=C(C=C(C=N1)C2=NC(=NO2)C3=C4C=CN(C4=CC=C3)CCCC(=O)O)Cl
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.